Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1999
12/23/1999CA2331834A1 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
12/23/1999CA2300892A1 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
12/22/1999EP0965623A1 Stabilized monomer adhesive compositions
12/22/1999EP0965597A1 Cell membrane-directed drugs
12/22/1999EP0965342A1 Preparation for percutaneous administration
12/22/1999EP0965339A1 Tabletted preparation
12/22/1999EP0965335A1 Metered-dose aerosol formulations
12/22/1999EP0965334A1 Liquid respiratory product for intubation
12/22/1999EP0965330A1 Cosmetic and dermatolic compositions containing chitosan and phospholipids
12/22/1999EP0965329A1 Skin treatment agents and use thereof for preparing dermatological compositions
12/22/1999EP0965321A1 Composition for external use
12/22/1999EP0964703A1 Inhibition of gene transcription by polyamide dna-binding ligands
12/22/1999EP0964690A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
12/22/1999EP0964676A1 Microparticles and their use in cancer treatment
12/22/1999EP0964675A1 Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it
12/22/1999EP0952770A4 System for rendering substantially non-dissoluble bio-affecting agents bio-available
12/22/1999EP0923382A4 Compositions of plant carbohydrates as dietary supplements
12/22/1999EP0889944B1 PROCESS FOR STABILISING AND DISPERSING VEGETABLE OILS WHICH CONTAIN POLYUNSATURATED FATTY ACID RADICALS BY MEANS OFgamma-CYCLODEXTRIN
12/22/1999EP0876160B1 Ligand directed enzyme prodrug therapy
12/22/1999CN1239480A Pharmaceutical compsns. containing an MPL ligand
12/22/1999CN1239436A Topical prepn. for introducing peptidaceous pharmacons in living organisms
12/22/1999CN1239432A Solid pharmaceutical compsns. comprising cyclosporin and anionic surfactant
12/22/1999CN1239427A Use of mupirocin for manufacture of medicament for treatment of bacterial infections associated with colonisation of nasopharynx by pathogenic organisms
12/22/1999CN1047666C Immunity detection method of releasing antigen from antibodies
12/21/1999US6005020 Bioresorbable compositions for implantable prostheses
12/21/1999US6005004 Polylysine, polyarginine and polyornithine bimolecular complexes
12/21/1999US6005001 Pharmaceutical composition
12/21/1999US6004996 Tetrahydrolipstatin containing compositions
12/21/1999US6004973 Pharmaceutical compositions comprising rafamycin coprecipitates
12/21/1999US6004969 Administering with drug penetration enhancer
12/21/1999US6004968 Viricides; free of ethylenediaminetetraacetic acid and ethanol; preservative efficacy
12/21/1999US6004951 Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
12/21/1999US6004949 Aqueous composition containing cromoglycic acid
12/21/1999US6004931 Method for inhibiting growth hormone action
12/21/1999US6004927 Coadministering bioenhancer comprising inhibior of cytochrome p450 3a or p-glycoprotein-mediated membrane transport
12/21/1999US6004925 Polypeptide anticholesterol agents; cardiovascular disorders, restenosis, atherosclerosis
12/21/1999US6004763 Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
12/21/1999US6004583 Protein-containing polymer composition for oral administration
12/21/1999US6004582 For immediate delivery of a first active agent followed by a monitored, continuous, controlled and/or retarded delivery of a second active agent which is the same or different as the first active agent; time-release agents
12/21/1999US6004580 Comprising hydrophilic component, lipophilic component, surfactant, drug; drug immobilized in microemulsion-based gel
12/21/1999US6004579 Aging inhibition; wound healing agent; preserving organs; treating dermatological conditions such as wrinkling, sagging, baldness, psoriasis
12/21/1999US6004578 For enhancing the percutaneous absorption of drugs when administered to a body surface or membrane
12/21/1999US6004575 Use of (meth) acrylic acid/maleic acid copolymers for improving mucosal permeability
12/21/1999US6004574 For administration of medically useful polypeptides, for administering polypeptides through inhalation
12/21/1999US6004573 Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
12/21/1999US6004566 Bioactive drug or cosmetic substance presented in the form of submicron oil spheres alone, or drugs or cosmetic substances in a combination with the oil spheres in an aqueous suspension or emulsion
12/21/1999US6004555 Methods for the specific coagulation of vasculature
12/21/1999US6004554 Methods for targeting the vasculature of solid tumors
12/21/1999US6004550 Intracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug system
12/21/1999US6004549 Crystalline protein controlled release compositions
12/21/1999US6004537 Inhaler comprising container of pressurized aerosol solution comprising budesonide, formoterol, fluoroalkane propellant, cosolvent present in amount to dissolve or solubilize mixture
12/21/1999US6004531 Metal chelating compounds having an SNNN donor set
12/21/1999CA2148311C Lipid vesicles, their process of production and their applications
12/21/1999CA2126441C Microcrystalline cellulose spheronization composition
12/21/1999CA2001325C Stabile parenteral solution of 2-phenyl-1,2-benzisoselenazol-3(2h)-one and process for producing the same
12/16/1999WO1999064622A1 Inhibition of coagulation in blood and blood products
12/16/1999WO1999064615A1 Formulations for electroporation
12/16/1999WO1999064595A1 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME
12/16/1999WO1999064574A1 Method to prepare c-terminal modified peptides
12/16/1999WO1999064547A1 Contaminant reduced marine oil
12/16/1999WO1999064465A1 Diluting and disintegrating composition, method for obtaining same and use thereof
12/16/1999WO1999064464A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
12/16/1999WO1999064460A1 Divalent antibody fragments
12/16/1999WO1999064449A2 Cell-permeable peptide
12/16/1999WO1999064441A1 Method for preparing virus-safe pharmaceutical compositions
12/16/1999WO1999064073A2 Recombinant immunotoxin directed against the hiv-1 gp120 envelope glycoprotein
12/16/1999WO1999064072A1 Conjugate consisting of a lectin and a blood coagulation factor
12/16/1999WO1999064071A1 A method for preparing a carbonized resin dna immunoadsorbent
12/16/1999WO1999064065A2 Tumour therapy and imaging
12/16/1999WO1999064059A2 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064054A1 Multibinding inhibitors of topoisomerase
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064051A1 Novel antibacterial compounds
12/16/1999WO1999064050A1 Novel potassium channel drugs and their uses
12/16/1999WO1999064049A1 Novel antibacterial agents
12/16/1999WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999WO1999064047A1 Novel antiviral compounds
12/16/1999WO1999064045A1 Novel therapeutic agents for membrane transporters
12/16/1999WO1999064044A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064016A1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063994A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063992A1 Novel calcium channel drugs and uses
12/16/1999WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999WO1999063984A1 Novel sodium channel drugs and uses
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
1 ... 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 ... 1712